(VIANEWS) – Catalyst Pharmaceuticals (CPRX), Fomento Economico Mexicano S.A.B. de C.V. (FMX), UBS Group (UBS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Catalyst Pharmaceuticals (CPRX)
83.2% sales growth and 35.89% return on equity
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Earnings Per Share
As for profitability, Catalyst Pharmaceuticals has a trailing twelve months EPS of $0.81.
PE Ratio
Catalyst Pharmaceuticals has a trailing twelve months price to earnings ratio of 15.28. Meaning, the purchaser of the share is investing $15.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.89%.
2. Fomento Economico Mexicano S.A.B. de C.V. (FMX)
46.8% sales growth and 11.51% return on equity
Fomento Económico Mexicano, S.A.B. de C.V., through its subsidiaries, operates as a bottler of Coca-Cola trademark beverages. The company produces, markets, and distributes Coca-Cola trademark beverages in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil, Argentina, and Uruguay. It also operates small-box retail chain stores in Mexico, Colombia, Peru, Chile, and Brazil under the OXXO name; retail service stations for fuels, motor oils, lubricants, and car care products under the OXXO GAS name in Mexico; and drugstores in Chile, Colombia, Ecuador, and Mexico under the Cruz Verde, Fybeca, SanaSana, YZA, La Moderna, and Farmacon names. In addition, the company is involved in the production and distribution of collers, commercial refrigeration equipment, plastic boxes, food processing, and preservation and weighing equipment; and provision of logistic transportation, distribution and maintenance, point-of-sale refrigeration, and plastics solutions, as well as distribution platform for cleaning products and consumables. Further, it operates small-box retail and food convenience chain stores in Switzerland, Germany, Austria, Luxembourg, and the Netherlands under the k kiosk, Brezelkönig, BackWerk, Ditsch, Press & Books, avec, Caffè Spettacolo, and ok.–) names, as well as pretzels under the Ditsch name. The company was founded in 1890 and is based in Monterrey, Mexico.
Earnings Per Share
As for profitability, Fomento Economico Mexicano S.A.B. de C.V. has a trailing twelve months EPS of $3.66.
PE Ratio
Fomento Economico Mexicano S.A.B. de C.V. has a trailing twelve months price to earnings ratio of 30.17. Meaning, the purchaser of the share is investing $30.17 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.51%.
3. UBS Group (UBS)
33.9% sales growth and 11.27% return on equity
UBS Group AG provides financial advice and solutions to private, institutional, and corporate clients worldwide. It operates through four divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, and Investment Bank. The Global Wealth Management division offers investment advice and solutions, and lending solutions. This segment also provides estate and wealth planning, investing, corporate and banking, and investment management, as well as mortgage, securities-based, and structured lending solutions. The Personal & Corporate Banking division provides personal banking products and services, such as deposits, cards, and online and mobile banking, as well as lending, investments, and retirement services; and corporate and institutional solutions, including equity and debt capital markets, syndicated and structured credit, private placements, leasing, traditional financing, trade and export finance, and global custody solutions, as well as transaction banking solutions for payment and cash management. The Asset Management division offers equities, fixed income, hedge funds, real estate and private markets, indexed and alternative beta strategies, asset allocation and currency investment strategies, customized multi-asset solutions, advisory and fiduciary services, and multi-manager hedge fund solutions and advisory services. The Investment Bank division advises clients on strategic business opportunities and helps them raise capital to fund their activities; enables its clients to buy, sell, and finance securities on capital markets and to manage their risks and liquidity; distribute, trade, finance, and clear cash equities and equity-linked products; and offers clients differentiated content on major financial markets and securities. The company was formerly known as UBS AG and changed its name to UBS Group AG in December 2014. UBS Group AG was founded in 1862 and is based in Zurich, Switzerland.
Earnings Per Share
As for profitability, UBS Group has a trailing twelve months EPS of $1.96.
PE Ratio
UBS Group has a trailing twelve months price to earnings ratio of 10.36. Meaning, the purchaser of the share is investing $10.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.27%.
Sales Growth
UBS Group’s sales growth is 0.9% for the ongoing quarter and 33.9% for the next.
Yearly Top and Bottom Value
UBS Group’s stock is valued at $20.30 at 01:22 EST, below its 52-week high of $22.30 and way higher than its 52-week low of $13.80.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 27.9% and a negative 15.4%, respectively.
Volume
Today’s last reported volume for UBS Group is 1474740 which is 53.2% below its average volume of 3151540.
4. UFP Technologies (UFPT)
16% sales growth and 20.95% return on equity
UFP Technologies, Inc. designs and converts foams, films, and plastics materials for the medical, automotive, consumer, electronics, industrial, and aerospace and defense markets in the United States. It offers single patient use surfaces, advanced wound care, infection prevention, and disposables for surgical procedures, endoscopic procedures, orthopedic implants, orthopedic appliances, biopharma drug manufacturing, etc.; molded components for automotive, aerospace, and defense markets; recycled protective packaging for B2C brands; and reusable cases and custom inserts. The company markets and sells its products through direct sales forces and independent manufacturer representatives. UFP Technologies, Inc. was founded in 1963 and is headquartered in Newburyport, Massachusetts.
Earnings Per Share
As for profitability, UFP Technologies has a trailing twelve months EPS of $6.07.
PE Ratio
UFP Technologies has a trailing twelve months price to earnings ratio of 32.35. Meaning, the purchaser of the share is investing $32.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.95%.
Volume
Today’s last reported volume for UFP Technologies is 49656 which is 57.27% below its average volume of 116216.
Sales Growth
UFP Technologies’s sales growth is 3.9% for the current quarter and 16% for the next.
5. ResMed (RMD)
15.5% sales growth and 23.93% return on equity
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, ResMed has a trailing twelve months EPS of $5.85.
PE Ratio
ResMed has a trailing twelve months price to earnings ratio of 36.98. Meaning, the purchaser of the share is investing $36.98 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.93%.
Volume
Today’s last reported volume for ResMed is 61776 which is 90.18% below its average volume of 629570.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 9, 2023, the estimated forward annual dividend rate is 1.76 and the estimated forward annual dividend yield is 0.82%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ResMed’s EBITDA is 95.8.
Moving Average
ResMed’s worth is under its 50-day moving average of $222.93 and below its 200-day moving average of $219.83.
6. Valmont Industries (VMI)
5.8% sales growth and 17% return on equity
Valmont Industries, Inc. produces and sells fabricated metal products in the United States, Australia, Brazil, Denmark, and internationally. The company operates through four segments: Engineered Support Structures, Utility Support Structures, Coatings, and Irrigation. The Engineered Support Structures segment manufactures and distributes engineered metal, steel, wood, aluminum, and composite poles, towers, and components for lighting, traffic, and wireless communication markets; engineered access systems; integrated structure solutions for smart cities; and highway safety products. The Utility Support Structures segment manufactures engineered steel and concrete pole structures for utility transmission, distribution, substations, and renewable energy generation equipment; and inspection services. The Coatings segment provides hot-dipped galvanizing, anodizing, and powder coating services to preserve and protect metal products. The Irrigation segment manufactures and distributes mechanical irrigation equipment, and related parts and services under the Valley brand name for the agricultural industry; and tubular products for industrial customers. This segment also provides water management solutions and technology for precision agriculture. The company serves municipalities and government entities, commercial lighting fixtures manufacturing companies, contractors, telecommunications and utility companies, and large farms, as well as the general manufacturing sector. Valmont Industries, Inc. was founded in 1946 and is headquartered in Omaha, Nebraska.
Earnings Per Share
As for profitability, Valmont Industries has a trailing twelve months EPS of $12.18.
PE Ratio
Valmont Industries has a trailing twelve months price to earnings ratio of 24.9. Meaning, the purchaser of the share is investing $24.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17%.
Sales Growth
Valmont Industries’s sales growth is 2.9% for the current quarter and 5.8% for the next.
Moving Average
Valmont Industries’s value is above its 50-day moving average of $286.53 and under its 200-day moving average of $305.66.
Volume
Today’s last reported volume for Valmont Industries is 136933 which is 8.37% below its average volume of 149454.
7. First Bancorp (FBNC)
5.4% sales growth and 10.6% return on equity
First Bancorp operates as the bank holding company for First Bank that provides banking products and services for individuals and small to medium-sized businesses. It accepts deposit products, such as checking, savings, and money market accounts, as well as time deposits, including certificate of deposits and individual retirement accounts. The company also offers loans for a range of consumer and commercial purposes comprising loans for business, real estate, personal, home improvement, and automobiles, as well as residential mortgages and small business administration loans; and accounts receivable financing and factoring, inventory financing, and purchase order financing services. In addition, it provides credit and debit cards, letter of credits, and safe deposit box rental services, as well as electronic funds transfer services consisting of wire transfers; and internet and mobile banking, cash management, bank-by-phone services, and remote deposit capture services. Further, the company offers investment and insurance products, such as mutual funds, annuities, long-term care insurance, life insurance, and company retirement plans, as well as property and casualty insurance products; and financial planning services. First Bancorp was founded in 1934 and is headquartered in Southern Pines, North Carolina.
Earnings Per Share
As for profitability, First Bancorp has a trailing twelve months EPS of $3.54.
PE Ratio
First Bancorp has a trailing twelve months price to earnings ratio of 8.71. Meaning, the purchaser of the share is investing $8.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.6%.
Yearly Top and Bottom Value
First Bancorp’s stock is valued at $30.84 at 01:22 EST, way under its 52-week high of $49.00 and way higher than its 52-week low of $26.26.
Moving Average
First Bancorp’s worth is higher than its 50-day moving average of $30.80 and way below its 200-day moving average of $38.24.
Revenue Growth
Year-on-year quarterly revenue growth grew by 0.9%, now sitting on 373.92M for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 28, 2023, the estimated forward annual dividend rate is 0.88 and the estimated forward annual dividend yield is 2.87%.
